Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency--early experience.
The authors reviewed results of digital subtraction vena cavography with a gadolinium-based contrast agent in 14 patients with serum creatinine levels greater than or equal to 1.5 mg/dL (133 mumol/L). All cavograms were diagnostic. In 11 patients, there was no impairment of renal function. In three patients, a rise in serum creatinine level of greater than or equal to 0.5 mg/dL (44 mumol/L) was attributable to concurrent medical problems. Gadolinium-based contrast agents may be suitable for digital subtraction vena cavography in patients with renal insufficiency.
Division of Vascular Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. kaufmanfamily@sprintmail.com
J A
JA
Kaufman
S C
SC
Geller
H
H
Bazari
A C
AC
Waltman
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015901:Angiography, Digital Subtraction; D002245:Carbon Dioxide / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D003404:Creatinine / Q000097:blood; D005260:Female; D005682:Gadolinium / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D051437:Renal Insufficiency / Q000000981:diagnostic imaging* / Q000209:etiology; D016306:Vena Cava Filters; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging*
D003287:Contrast Media; D002245:Carbon Dioxide; D005682:Gadolinium; D003404:Creatinine